Published July 8, 2022
| Version v1
Presentation
Open
Implementation of water-soluble crosslinked cyclodextrin-based polymers for light-activated combination therapy
Description
Abstract submitted for the Supramol2022 conference in Salerno in June 2022. Manet I was invited to give a keynote lecture.
Files
extract keynote.pdf
Files
(10.3 MB)
Name | Size | Download all |
---|---|---|
md5:88720234b70621d46290b4ad56bebb59
|
10.2 MB | Preview Download |
md5:7ecd636a8fde4f22059fd4a2b03104a3
|
62.0 kB | Preview Download |
Additional details
Funding
- HypoCyclo – Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions 894942
- European Commission
- CYCLON HIT – NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS 608407
- European Commission
- CYCLON – Novel multifunctional cyclodextrin-based nanocarriers for drug encapsulation and delivery as a strategy to overcome current therapeutic drawbacks. 237962
- European Commission
- POLAR STAR – Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer 843014
- European Commission